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Complementary  DNA (cDNA) that codes for a major 
androgen-dependent secretory protein of rat coagulat- 
ing gland and  dorsal prostate, dorsal protein 1 (DPl), 
was isolated by molecular cloning. Recombinant DP1 
cDNA clones were identified from a bacteriophage X 
gt  11 rat coagulating gland expression library using an 
affinity purified polyclonal antibody. Amino acid se- 
quence deduced  from  DNA contained sequences iden- 
tical with several DPl cyanogen bromide cleavage 
fragments. Northern blot hybridization of poly(A) 
RNA isolated from intact rat dorsal prostate and co- 
agulating gland revealed a predominant messenger 
RNA  (mRNA) species of approximately 3200 nucleo- 
tides. Tissue-specific expression of DP1 mRNA was 
indicated by the absence of DP1 mRNA in ventral 
prostate and other tissues of the rat. Expression of DP1 
mRNA was androgen-dependent, decreasing approxi- 
mately 80% 7 days after castration and increasing 
rapidly following androgen replacement. Southern 
blot analysis of restriction enzyme-digested rat DNA 
indicated that DP1  is encoded by a single gene and that 
no major genomic rearrangements accounted for its 
lack of expression in the dorsal prostate-derived rat 
Dunning tumor. Sequence comparisons revealed that 
rat prostate DP1 shares sequence identity with Factor 
XIIIa  and tissue transglutaminase, including the active 
center, GQCWVF, indicating that DP1  is a member of 
the transglutaminase gene family. 
The multiple lobes of the  rat  prostate  synthesize  in  response 
to  androgen  several abundant  proteins  destined for secretion 
into  the  seminal f uid.  Although the  functions of most of these 
proteins  remain  unknown,  they have  served as useful indica- 
tors for studies on androgen regulation of prostate gene 
expression (1-8). Two  anatomically  distinct regions of the  rat 
prostate complex are  the  anterior lobes, known as  the coagu- 
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lating glands, and dorsal lobes. Each coagulating gland is 
situated  on  the concave  side of the  seminal vesicle, whereas 
the  dorsal  prostate  forms a portion of the  prostate complex 
that includes the  lateral  prostate  and  surrounds  the  urethra 
at the neck of the bladder (9). Despite their anatomical 
differences, the coagulating gland  and  dorsal  prostate  synthe- 
size a  common abundant  protein  referred  to  as  dorsal  protein 
1 (DP1)l (9). Western  blot  analysis  and  immunoblotting 
revealed DP1  in  the  glands  and  ducts of rat  type 1, but  not 
type 2, lateral  prostate  (10).  DP1  is a 150-kDa dimeric protein 
(62 kDa on SDS-polyacrylamide gels) that  constitutes  about 
25% of total intracellular protein (9). In uitro translation 
studies  indicated  another major protein  that is highly glyco- 
sylated,  DP2,  and  secreted  in  abundance by the  dorsal  pros- 
tate  and coagulating glands (11). 
In  this  report,  an  affinity-purified  DP1  antibody was used 
to isolate DP1 cDNA clones from a library of coagulating 
gland  cDNA recombinants  in  the bacteriophage X gtll expres- 
sion  vector. The polymerase chain  reaction  (PCR)  and  rapid 
amplification of cDNA  ends  method were used to complete 
the 5”terminal end of the coding and noncoding regions. 
Amino acid sequence deduced from the cDNA matched  the 
sequence of cyanogen  bromide fragments of the purified pro- 
tein,  indicating  that  the cDNA is authentic. Expression of the 
3.2-kb DP1  mRNA species  was  tissue-specific and regulated 
by androgen.  DNA sequence analysis  indicates  that  rat  pros- 
tate  DP1  is a  member of the  transglutaminase family. 
EXPERIMENTAL  PROCEDURES 
Antibody  Production  and  Protein  Sequence-DP1 was purified and 
used as immunogen to  raise  rabbit polyclonal antibodies  as previously 
described (9). DP1 antibodies were affinity-purified by coupling DP1 
(5 mg/ml gel) to  CNBr-activated Sepharose 4B according to the 
manufacturer’s specification (Pharmacia LKB Biotechnology Inc.). 
Anti-DP1 antibodies were eluted with 0.2 M glycine HCl, pH 2.5, 
containing 0.5 M NaCl and  neutralized immediately  using 1 M Tris. 
To determine protein sequence, purified DP1 protein was reduced 
and  carboxymethylated  (12)  and cleaved with cyanogen  bromide (13). 
The cleavage products were separated using  high performance liquid 
chromatography  and sequenced  by automated  Edman  degradation  as 
previously  described (14). 
Preparation of RNA,   cDNA,  and  the X gtll  Library-The prostate 
lobes and  control  tissues were dissected  from adult  intact  or  castrated 
Sprague-Dawley rats (250-350 g) or from castrated  rats  treated with 
testosterone  propionate  as described  (15). Tissues were quick-frozen 
in liquid nitrogen.  Total  RNA was isolated  using the guanidine HCl 
method (16) and enriched for poly(A) RNA by oligo(dT)-cellulose 
The abbreviations used  are: DP1,  dorsal  protein 1; PCR, polym- 
T G ,  transglutaminase;  SDS, sodium dodecyl sulfate;  kb, kilobaseb); 
erL chain reaction; oligo, oligonucleotide; pfu, plaque-forming unit; 
bp,  base  pair(s);  PIPES, 1,4-piperazinedlethanesulfonic acid. 
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chromatography (17). Single stranded cDNA was synthesized from 
a n  oligo(dT)  primer,  and  RNA was  removed by treatment  with 0.3 M 
NaOH overnight at 37 "C. A 5' hairpin loop served as primer for 
second  strand  synthesis. cDNA was recovered by chromatography  on 
Sephacryl S-300 (17). Cleavage with S1 nuclease (17) preceded meth- 
ylation of EcoRI sites  with  EcoRI  methylase  and  S-adenosylmethio- 
nine.  The cDNA was ligated to  EcoRI  linkers  and cloned into X gtll. 
described (18). 
Cell extracts and in vitro packaging were prepared as previously 
The original library  contained 3.6 X lo5 plaque-forming  units  (pfu), 
of which 2.73 X lo5 formed wild type blue plaques and 8.7 X lo4 
recombinant colorless plaques when grown in  the  presence of isopro- 
pyl 8-D-thiogalactopyranoside and 5-bromo-4-chloro-3-indolyl p-D- 
galactoside. The recombination frequency  was 24%. The library was 
amplified in  E. coli Y1088 to  9.5 X 10" pfu on  agar  plates,  and  phage 
were  eluted  in SM (0.1 M NaC1, 10 mM MgSO,, 0.1% gelatin,  and  50 
mM Tris, pH 7.5). The library was screened for recombinants as 
described by Young and Davis (19) using affinity-purified  anti-DP1 
antibody (0.6 mg/ml) a t  a 200-fold dilution  and 0.85% gelatin  rather 
than fetal calf serum  to block nonspecific binding sites. X phage were 
plated on lawns of E. coli Y1090 and incubated a t  42 "C for 1 h. 
Nitrocellulose filters  saturated  with  10 mM isopropyl  P-D-thiogalac- 
topyranoside were overlaid, and  incubations were continued at  37 "C 
for 3 h. Filters were incubated with a 1/200 dilution of affinity- 
purified DP1 antibody, washed, and incubated with '"1-protein A. 
Positive clones were detected by autoradiography. 10; plaques  on a 
150-mm  plate were screened, and positive  plaques were selected and 
incubated overnight in SM. Phage from positive plaques were re- 
screened a t  300 plaques on a 90-mm  plate. The  third  screen of selected 
plaques were all  positive. 
h DNA was prepared  as described  previously  (17,  20). Rat  prostate 
DNA was isolated as described by Blin  and  Stafford  (21).  Northern 
and  Southern  blot  analysis were performed  as described  previously 
(22-24) a t  42 "C  in  the  presence of 50% formamide  and 0.1% SDS. 
Filters were washed a t  high stringency in 0.1 X SSC (1 X SSC: 15 
mM NaCl, 1.5 mM sodium citrate, containing 0.1% SDS  at  60 "C). 
The  DNA  sequences of both  strands were fully determined  using  the 
chemical cleavage (25) and Sanger dideoxy (26) methods. Assign- 
ments of nucleotide numbers for DP1 cDNA clones and oligonucleo- 
tides were based on  the  designation of nucleotide 1 as  the  first residue 
at the 5' end of DP1 cDNA, determined by PCR,  and verified by 
genomic DNA sequence analysis. Oligonucleotide primer sequences 
are listed in ascending (5'-3') or descending (3'-5') order. PCR 
products were cloned into  M13 mp19, and  both  strands of a t  least 
three clones were sequenced using  the dideoxy method. 
5' End of DP1 cDNA-The method of rapid  amplification of cDNA 
ends described by Ohara et al. (27) and Frohman (28) with some 
modifications was used to  generate  the  5' region of DP1 cDNA. First 
strand cDNA was prepared from  coagulating gland poly(A) RNA,  and 
a stretch of dG residues was added to the 3' end using terminal 
deoxynucleotidyltransferase. The first cycle of the 100 p1 PCR reac- 
tion  containing oligonucleotide  (oligo)  A (40  bp)  and B (433-395) (see 
Table I )  was as follows: denaturation  at 95 "C, 5 min;  annealing at  
55 "C, 1 min; extension a t  72 "C, 1 min. Oligo A contains 20 repeated 
deoxycytosine  residues at  its  3'  end  and  three  5'  restriction enzyme 
sites:  HindIII, EcoRI, and  BamHI  (Table I). The  PCR  reaction was 
continued for 40 cycles: denaturation at 95 "C, 40 s; annealing a t  
55  "c,  1 min;  extension at  72 "C, 1 min  plus 3 s/cycle. One-tenth of 
the reaction product  (10  pl) was reamplified with oligonucleotide  A 
and  the  nested oligo C (153-119) (see  Table I) using the above PCR 
conditions. 
Primer Extension Analysis-Primer extension was performed as 
described previously (29), with some modifications. Briefly, the 5' 
end "P-labeled  oligonucleotides C, E, and F (Table I) were incubated 
with increasing amounts (0.01-1 pg) of coagulating gland poly(A) 
RNA in a solution containing 50% formamide, 0.4 M NaC1, 1 mM 
EDTA,  and 40 mM PIPES,  pH 6.4, at  85  "C for  10  min and placed a t  
42.5 "C for 4-6 h. After ethanol  precipitation,  the oligonucleotide was 
extended  with  avian myeloblastosis virus reverse transcriptase  (Pro- 
mega Biotec, GIBCO-BRL) using DP1 mRNA as template. DNA 
products were subjected to  electrophoresis  on a 5% sequencing gel in 
parallel  with dideoxy  sequencing ladders of M13  mp19 size markers. 
RESULTS 
Identification of DPI  cDNA-A cDNA expression library 
of 3.6 X lo5 pfu was prepared from rat coagulating gland 
poly(A) RNA using the X gtll cloning system  and amplified. 
Screening of approximately 3 X IO6 pfu  with  affinity-purified 
anti-DP1  antibody yielded 27 positive clones. The clones were 
digested with EcoRI and  analyzed  on agarose gels; 15 were 
selected for further analysis based on their different sized 
inserts  (not  shown).  The  smallest  insert from clone 15 was 
sequenced by the Maxam/Gilbert chemical cleavage proce- 
dure  (25)  and  found  to  contain a 221-bp open reading frame 
that included the predicted amino acid sequence of DP1 
peptide 7  (see  Fig. 1). Identity between protein  and  predicted 
sequence  suggested that  the isolated DNA  represented a par- 
tial sequence of DP1.  Southern blot analysis of EcoRI  digested 
DNA from each of the positive clones probed with a '"P- 
labeled insert  DNA from  clone  15 indicated  the  presence of 
common sequences among all 15 clones that ranged in size 
from 221 bp (clone 15) to  approximately 1900 bp (clone 11) 
(data not shown). The position of clone 15 in  the  DP1 se- 
quence was later  determined  to be nucleotide  residues 1290- 
1510. The  largest cDNA  clone  (clone 11) contained 1902 bp 
positioned at  378-2279 (excluding a 5' inverted region, see 
below) where the  numbers refer to  the  putative mRNA start 
site (see below and Fig. 2).  The  chain  termination codon at  
residues 2073-2075 (Fig. 1) ended a 2004-bp open reading 
frame.  Two  additional  stop codons were observed at residues 
2082-2085 and 2091-2093. 
To  further  establish  the  identity of clone 11, the deduced 
amino acid  sequence was compared  with amino acid  sequence 
determined directly from purified DP1. The presence of a 
blocked NH,  terminus  necessitated chemical cleavage of DP1 
with CNBr prior  to sequence  analysis. The sequences of nine 
CNBr fragments were obtained, five of which matched the 
deduced  sequence of cDNA  clone 11 (peptide  fragments 4-8 
shown underlined in Fig. 1). In each instance, the peptide 
sequence was preceded by a methionine residue in the  pre- 
dicted amino acid sequence of clone 11, in agreement with 
TABLE I 
Sequence of oligonucleotide primers used in PCR amplification of the 5' end of the DPI cDNA 
All sequences are  listed  in  the 5' to  3'  direction.  Numbers at   the right  indicate  the  sequence position,  where 1 is the  mRNA  initiation site. 
Numbers  increasing  are  5' to 3' and  numbers  decreasing  are  5'  to  3' of the opposite strand shown in Fig. 1. Oligonucleotides  F and G were 
determined  not  to he DP1 sequence and  are derived from  the  5'  end of clone 10. The sequence of oligonucleotide  H was based  on  sequence 
obtained by PCR. 
A GCACAAGCTT  GAA CGGAT SCCCCCCCC CCCCCCCCCC 
H i n d I I I  EcoRI BamHI 
B CCAGCGTCAA ATTCGTTCAC GTTCATCGTG TACCTCCCC 
C GGTACTCAAT CGTGTGGTGG GCAGCAGCGT TCAGC 
D GCTTGTCGTT TACTCTGTGA AC 
E CCAACCCTGT CAAGTCTCCA GTCTGATG 
F CCAGTCCCGG TAGTGTTTCG C 
G GAGAAAGTAT AACTGGAGTG CCAAGG 
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1 GAGAGTGACTCTGGCIGCGCTGGCATCAGACTGGAGACTTGACAGGGTTGGAGAGAGGCAGCAGG 
1 
6 6  ACCATGGACTCCAGGMCATGCTTGTCGTTTACTCTGTGMCTTGGAG~GCTGMCGCTGCT 
10  20 
, n e t ~ ~ ~ c r A . 1 ~ & n ~ e t L e u V a l V a 1 T Y r S e r v a l ~ n L c u ~ l u L Y s L Y ~ L e u A ~ n A l a A l a  J U  1 0  
132 GCCCACCACACGATTGAGTACC~CTCAGMGCTCGTGCTCAGGCGTGGACAGATATTCTCCCTG 
A 1 a ~ l s H l ~ T h r ~ l e G 1 ~ T ~ ~ G l n T h r G l n L y s L e u V a l L ~ ~ A ~ g A ~ q G l y G l n l l e P h e S e r L ~ u  
198 MGGTGATGCTAMCAGACCGCTCCMTCTCATGATGMCTGMGCTGATATTCMTACTGGACAC 
L y s V a l M e t L e u A ~ n A ~ q P r o L e u G l n S e ~ U ~ ~ & p G l u L ~ ~ L y ~ L ~ u l l e P h e & n T h r G l y ~ l s  
264 MCATGCCATTCTACACTCTCGAGCTTGATCCMTGACATCCTACCGTTCCMGGGCTGGCAGGTG 
50 6 0  
2 10 80 
A~nnetProPheTyrThrValGluLeuA~pPro~~tThtEerTyrA~~StrLY~GlyTrpGlnVal - 
3 3 0  MGATTGCT~CAGTCTGGTGTAGAGGTTGTATTGMTGTCATCAGTGCTGCCMCGCCGTGGTG 
3 9 0  4 100 
L y ~ f l e A l a L y s G l n S c r G 1 y V ~ l G l u V ~ l V ~ l L ~ ~ & n v ~ l ~ l ~ S ~ ~ A l a A l a ~ ~ A ~ a V a l V a l  




















220  230  240 
+ * 260 
858 ACAGCACTGAGAGCAGTGGGCATCCCAGCTCGCAGCGTGACTMCTTTGAGTCAGCCCACGATACA 




MpSerValTrpMnPhe~lJMetTrpThr&pAlaT~ ~etLy~ArqGlnMDLeUProGlnGly  
1056 CATG~TGGTTGGCAGGTCCTGGATTCTACACCACAGG~TCAGTGMGGACMTTCCGCATTGGA 
HISAaDG1~rpGlnValLeu&pSerTh~ProGlnGluIl~strGluGlyGlnPh~ArglleG~y 
210  280 
290 300 
310 320 
330  340  350 








S e r H l ~ A r q C y ~ G l y & p C y ~ A ~ a S e r l l e G l y L y ~ & ~ ~ ~ e S ~ r T h r L y ~ M e t V a l G l ~ G l u & n  
”. ~ . .  
400  410 
420 4 30 7 
1320 AGGCGTCMGATATTACCTTGCATTACMGTTCCCAGMGGCAGCCCAGAGGAGAGGMGGCCATG 
~ ~ A I q G ~ n M D I l e T h r L e u H l ~ T y r L y ~ P h e P r  luGly 
1386 GAGMGGCCTCTCCC~CGTCCTGATGACMGCTCMCTCTCGGACACTTCACATATCTGTCCTC 
440  450 
G~ysAlaStrGlyLysAtqPro&pAspLyJL~uMnStrArgThrLeuH~~~l~SeIValLeu 
1452 CAGMCTCTGTGGAGCTAGGACATCCTATCMTTTGACCATAGTGTTG~GG~CGGCCACA 
C l n M n ~ L e u G 1 y H l ~ P r o I l e ~ l l t V a l L t u L y s A r q L y s T h r A l a T h t  
410  480 
1516 CCACAGMTGTCMCATTTCATGCTCCCTTGACCTACAGACTTACACAGGCMCMGMGACAMC 




530  540 8 
1650 TCCAGTTTCTACATCTAT~CTGGGCATGGTTGATGATGAGATGGTCATT~GGGTTCATCATT 
g c l B C I P h e T Y r I L e u G l y M e t V a l M p A s p G l ~ M t t v a l l l e L y s C l y P h e l l e I 1 e  





580  590 
PheS@rValGlunetPr~se~ThrEerLy~ValMnGlnProLeuThrIleThrCysAsnPheLys 
1848 MCACCCTGCCCATCCCTTTGACTMCATCMGTTCTCAGTGG~GCCTGGGCCTCMTMCATG 
600  610 
MnThrLeuProIleProLeuThrMnIleLysPhe &y+#SerLeuGlyLeuASn&nnet 
1914 MGTCCTCGGAGCMGAGACGGTGCCGCCCGG~GACCATCMTTTCCAGATAGMTGCACCCCA 
















FIG. 1. Nucleotide sequence of DP1 cDNA and its derived 
amino acid sequence. Regions of alignment with eight CNBr cleav- 
age fragments obtained from purified DP1 protein are underlined. 
Possible sequences for glycosylation are double underlined: Asn-X- 
Ser and Asn-X-Thr for N-glycosylated oligosaccharide and Ser-X- 
Glu for 0-glycosylated oligosaccharide (47, 58). Two possible se- 
quences for formation of a hairpin loop structure are indicated at 
residues 12-18 and 378-384 (ouerlined). The putative active center 
CNBr cleavage at methionine residues. 
TO our surprise, one CNBr peptide sequence was encoded 
by the opposite strand at  the 5‘ end of clone 11, indicating 
the possibility of a cloning inversion (shown correctly as 
peptide 1 in Fig. 1). The putative inversion contains sequences 
135-17 (shown correctly as 17-135 in Fig. 1) contiguous with 
residue 378 of clone 11. Two additional cDNA  clones, detected 
by rescreening the coagulating gland cDNA library with a 5’ 
portion of clone 11 cDNA, terminated in the region of residue 
378. These results suggested that secondary structure near 
residue 378 interfered with cDNA extension during library 
preparation.  This hypothesis was later supported by the iden- 
tification of a GC-rich sequence with complementarity be- 
tween residues 12-18 and 378-384 (ouerlined in Fig. l). Fur- 
thermore,  PCR analysis confirmed the inversion as discussed 
below. DNA inversions of this  type at  the 5’ end of cDNA 
clones were reported previously (30-34). 
Determination of the 5’ End of DPl cDNA-Since several 
peptide sequences were not identified in the deduced amino 
acid sequence and  there was evidence for a 5’ inversion, an 
additional cDNA clone 10 was isolated (Fig. 2) by rescreening 
the rat coagulating gland cDNA library using a 5’ 270-bp 
HpaII fragment from clone 11. Clone 10 contained 249 bp 
within which two regions of amino acid sequence matched 
two as yet unidentified DP1 peptide fragment sequences, 
which are shown as peptides 1 and 2 (underlined in Fig. 1; 
diagrammed in Fig. 2). However, no overlapping sequence was 
detected that linked clones 10 and 11. Furthermore and as 
discussed below, the 5‘ 99 bp of clone 10 were not DP1 
sequence. 
PCR was used to determine the missing sequence between 
cDNA clones 10 and 11. Two oligonucleotide primers, oligo B 
(433-395) and oligo D (86-107),  were prepared with sequence 
derived from clones 11 and 10, respectively (Fig. 2, Table  I). 
An amplified fragment of 348 bp (shown schematically in Fig. 
2) represented nucleotide residues 86-433 and  had an open 
reading frame continuous with the flanking sequence of cDNA 
clones 10 and 11. Furthermore, the 139-bp gap sequence 
between clones 10 and 11 obtained by PCR extended from 
residues 239-378 and  contained the sequence encoding pep- 
tide fragments 3  and 4 shown in Figs. 1 and 2. 
The 5’ terminal sequence of DP1 cDNA  was obtained by 
the method of rapid amplification of cDNA ends. First  strand 
cDNA template was extended with dG residues using terminal 
deoxynucleotidyltransferase to provide a  substrate for priming 
with 5’ oligo A (see “Experimental Procedures,” Fig. 2, and 
Table I). In an initial PCR reaction using oligos A and B 
(433-395), no prominent  band was detected by ethidium bro- 
mide staining of an agarose gel. The  PCR reaction mixture 
was further amplified using oligos A and  C (153-119,  Fig. 2). 
A 193-bp fragment was obtained (shown schematically in  Fig. 
2) that contained an open reading frame but coded for no 
additional CNBr peptide sequences of DP1. The 193-bp frag- 
ment hybridized to  the 3.2-kb DP1 mRNA, suggesting that  it 
represented authentic DP1 sequence (data  not shown). How- 
ever, sequence comparisons revealed that  the 5’ 106 bp of the 
193-bp PCR fragment differed from clone 10, yet 87 bp of  3‘ 
sequence matched the sequence in  clone 10; the boundary of 
the two was a HinfI site in clone 10 (see Fig. 2). 
To establish the correct 5’ end of DP1, primer extension of 
the cDNA was performed using, as primers, oligos C (153- 
119), E (51-24), and F (54-34) (see Table  I  and Fig. 2). Primer 
extension with oligo C yielded a 153-bp fragment (Fig.  3, lanes 
cysteine for transglutaminase activity (asterisk) and the potential 
Ca2+-binding site (boxed) are indicated. The first 50 nucleotide resi- 
dues were verified by genomic DNA sequence analysis. 
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FIG. 2. Schematic  diagram of the  cloning, PCR, and  sequencing strategy used to obtain  the  DP1 cDNA sequence. A ,  shown 
are the relative positions of cDNA clones 10,11, and 25, The coding sequence is indicated by solid bars, noncoding regions by lines, and DNA 
sequence not belonging to DP1 by doshed  lines. CNBr peptide fragments and PCR-amplified DNA fragments are also indicated. Oligonucleotide 
primers  used  in PCR and primer extension are shown as arrows and are lettered in accordance with Table I .  A HinfI site in clone 10 occurs 
at the junction between 3' authentic DP1 sequence and a 5' cloning insertion. The 119-bp cloning inversion that occurred  in clone 11  began 
at residue 378 and proceeded  in the 5' direction and is not illustrated. Residue numbers  are indicated relative to the predicted mRNA start 
site. B,  the strategy for DNA sequencing is diagrammed using either Maxam/Gilbert chemical cleavage or Sanger dideoxy methods. Arrows 
indicate the sequencing directions. The restriction enzyme sites shown were  used  in sequencing: A ,  AluI;  H,  HaeIII;  HP,  HpaII; S , ScaI. The 
DNAs derived  from cDNA clones or subclones with their relative positions correspond to that in A above. 
7 and a), and  with oligo E, a 51-bp  fragment (Fig. 3, lanes 5 
and 6). These  results were in  agreement  with  the  193-bp  PCR 
amplification product reflecting authentic 5' sequence (153 
residues + the 40-residue oligo A). Oligo F failed to yield an 
extended product (Fig. 3, lunes 1-3). Since  the sequence of 
oligo F derives from the 5' region of clone 10, a cloning 
artifact  must have arisen  in  this region perhaps by insertion 
of an EcoRI fragment at the HinfI site. 
Further proof for the authenticity of DP1 5' sequence 
utilized an  alternative  PCR  strategy. Oligo G (1-26 of clone 
10, see Table I and Fig. 2) sequence  was  derived from  the 5' 
end of clone 10  that was suspected of being a cloning  insertion 
artifact.  The sequence of oligo H-(1-23) was derived  from the 
5' end of the amplified 193-bp  fragment  thought  to  be  the 
correct 5' DP1 sequence (Fig. 2). Each of these oligos was 
used in PCR paired with oligo C-(153-119) or B-(433-395, 
see Fig. 2). Only the oligo pairs H/C and H/B yielded the 
expected products of 153  and 433 bp, respectively. As pre- 
dicted, the G/C and G/B oligo pairs failed to yield PCR 
amplification products, indicating that the 5' 99 bp of the 
249-bp  clone 10 was not  authentic  DP1 sequence and  repre- 
sented a  second cloning  artifact.  Further evidence that  the 5' 
region of clone 10 was not derived from DP1 came from 
Northern  blot  analysis using the 5' HinfI fragment  as probe; 
it failed to hybridize with  DP1 poly(A) RNA. The 3' HinfI 
fragment of clone 10 showed strong hybridization with  DP1 
mRNA  (data  not  shown). 
Preliminary  analysis of genomic DNA  indicates  an  intron 
of undetermined size positioned between  nucleotide  residues 
84 and 85. A 5' genomic fragment was obtained, however, 
that allowed us to confirm the 5' cDNA sequence. Several 
additional large introns  within  the genomic sequence inter- 
rupted  the coding  sequence at residues 389,466,  and 585. An 
additional 722 bp of 3"noncoding cDNA sequence (Fig. 1) 
were determined from the 2-kb insert of clone 25 (shown 
schematically  in Fig. 2) making a 3000-bp cDNA. 
Regulation of DPl mRNA-A 32P-labeled 270-bp HpaII 5' 
fragment of DP1 cDNA  clone 11 was used as a hybridization 
probe  to  determine  mRNA levels in  the  intact  rat  and  under 
conditions of androgen withdrawal and  restimulation.  North- 
ern  blot  analysis of poly(A) RNA isolated  from dorsal  prostate 
and  coagulating gland  revealed  a prominent  band of approx- 
imately 3.2 kb (Fig. 4A, lanes D and C), which was absent  in 
poly(A)-depleted  RNA of coagulating  gland  (Fig. 4.4, lane 2'). 
The  similarity  in  band  intensity of DP1  mRNA in  coagulating 
gland and  dorsal  prostate  is  in  agreement with earlier  studies 
indicating that DP1 is a major product of these prostate 
regions. Poly(A) RNA of ventral prostate (Fig. 4A, lane V )  
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FIG. 3. Localization of the 5' end of DP1 by primer  exten- 
sion. "2P-Labeled oligonucleotides were incubated with coagulating 
gland poly(A) RNA and extended by reverse transcriptase using 
coagulating gland poly(A) RNA as template: lanes 1-3, extension with 
oligo F; lanes 4-6, extension with oligo E lanes 7-9, extension with 
oligo C. The amount of poly(A) RNA used was 0.01 pg (lanes 1, 4, 
and 9), 0.1 pg (lanes 2,5, and 8),  1 pg (lanes 3, 6, and 7). An M13 
mp19 sequencing ladder (GACT) determined by the dideoxy method 
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FIG. 4. Northern blot hybridization of RNA from the rat 
prostate,  Dunning  R3327  prostate  tumor, and other tissues. 
A, hybridizing bands are shown with poly(A) RNA from  dorsal 
prostate (D) and coagulating gland (C) but not with poly(A)-deprived 
coagulating gland RNA (T), poly(A) RNA from ventral prostate ( V ) ,  
or poly(A) RNA from the Dunning tumor (H). RNA samples (20 pg) 
were glyoxylated and electrophoresed on a 1% agarose gel and trans- 
ferred to a Biodyne nylon membrane. The membrane was hybridized 
to a '"P-labeled cDNA from the 5' end  of  clone 11, washed at high 
stringency, and exposed to x-ray film. B, total RNA was isolated from 
ventral ( V ) ,  dorsal (D), and lateral (L) lobes of prostate, coagulating 
gland (C), seminal vesicle (S) ,  and epididymis (E). RNA samples 
were processed as described in A. 
lacked  a  signal for  DP1 mRNA, as did  poly(A)  RNA  isolated 
from the Dunning R3327H tumor (Fig. 4A, lane H ) .  The 
Dunning  tumor  is  thought  to  originate from the  rat  dorsal  or 
vtaminase from Rat Prostate 
lateral  prostate (35). Sublines of the  Dunning  tumor including 
the G, AT1, AT3, ML, MLL, HI,  and  HIF (36) also lacked 
DP1 mRNA (data not shown). Using total RNA, no DP1 
mRNA signal was observed in ventral  prostate  or epididymis 
(Fig. 4B, lanes V and E ) ,  and weak signals were detected  in 
lateral  prostate  and  seminal vesicle RNA (Fig. 4B, lanes L 
and S,  respectively). These  latter signals likely resulted from 
a failure to completely  dissect these glands  free from dorsal 
prostate  and coagulating  glands. 
Androgen regulation of DP1 mRNA was examined by iso- 
lating RNA from dorsal  prostate of rats  castrated  and sacri- 
ficed at intervals  up  to 7 days. As shown in Fig.  5A, the high 
steady  state level of the 3.2-kb DP1 mRNA in  intact dorsal 
prostate decreased  by 20% within 1 day and by 80% within  7 
days  after  castration.  Administration of testosterone propio- 
nate  (2 mg intramuscularly)  to  animals 4 days after  castration 
rapidly  increased the level of DP1 mRNA (Fig. 5B).  Within 
4 h, the 3.2-kb mRNA species increased 2-fold, and within 8 
h of androgen treatment, by 4-fold. After a slight decline 
between 12-16 h,  DP1 mRNA continued  to increase up  to 72 
h of androgen  stimulation. The RNA band at approximately 
2.1 kb  is  attributed  to cross-hybridization with 18 S ribosomal 
RNA,  based on  its size and reactivity  with other DNA probes. 
The decrease  in DP1 mRNA after  castration could result 
from a change  in  mRNA  turnover  or f om  a  decreased rate of 
transcription. To investigate this further, cycloheximide, a 
reagent known to stabilize  rapidly turning over mRNAs  (37), 
was administered to 350-g rats.  Four days after  castration, 
rats were either  untreated  or  treated with testosterone pro- 
pionate 30  h prior  to sacrifice. Cycloheximide (20 mg intra- 
peritoneally) injected  2  h before sacrifice  increased the level 
of DP1 mRNA by 2.3-fold in  untreated  castrated  rats  but did 
not cause an increase after 30  h of androgen stimulation (Fig. 
6).  In a  previous study  under identical  conditions, cyclohexi- 
mide  caused  a 7-fold increase in  the level of c-myc mRNA of 
ventral  prostate  in  untreated  castrated  rats  but only  a 2-fold 
increase  30  h after androgen replacement (38). These  results 
suggest that  in  the absence of androgen,  DP1 mRNA  degra- 
dation is more  rapid, and like c-myc mRNA, it  can be stabi- 
lized by cycloheximide. Androgen stimulation itself appears 
to stabilize DP1 mRNA and decrease its  rate of degradation 
since cycloheximide did not increase DP1 mRNA after  andro- 
gen treatment (Fig. 6). 
One Gene Locus for DPI-In  an  attempt  to  establish if DP1 
mRNA is encoded by a single gene, total genomic DNA was 
isolated from rat  dorsal  and  ventral  prostate  and from the 
R3327H Dunning tumor. DNA was digested with several 
restriction enzymes known not  to cleave within DP1 cDNA 
clone 11 (BamHI, BglII, PstI,  PuuII, EcoRI, and  SstI). Using 
the  entire 2021-bp cDNA insert of clone 11 as a radiolabeled 
probe, a smear  on  the autoradiogram was observed, probably 
resulting from cross-hybridization of an Alu-like repetitive 
element a t  nucleotides 2175-2251 within the 3"noncoding 
region of clone 11. Genomic  DNA was then analyzed  using 
the 5' HpaII fragment of clone 11. Digestion with each of 
several restriction enzymes (BamHI, BglII, and EcoRI) 
yielded a single band using DNA isolated from dorsal and 
ventral  prostate  and  Dunning  tumor (Fig. 7,  A-C), suggesting 
the presence of one gene locus for  DP1. Digestion with PstI, 
PuuII,  or  SstI yielded two or  three bands, which likely resulted 
from  enzyme cleavage within  intron regions. One gene locus 
for DP1  is  consistent with  findings  using an EcoRI partially 
digested rat genomic DNA library constructed in X Charon 
4A and provided by T. Sargent, R. Wallace and J. Bonner, 
California Institute of Technology (39). Two  DP1 genomic 
DNA  clones  isolated thus  far have  identical  restriction pat- 
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FIG. 5. Effect of castration and androgen replacement on DP1 mRNA in dorsal prostate. A, dorsal  prostate was removed from 
groups of rats  that were intact ( in t )  or  castrated  and sacrificed 1, 2, 4, and 7  days  later. B, total  RNA was  isolated from dorsal prostate of 
intact  rats  and from rats that were administered  testosterone  propionate  (2 mg intramuscularly) 4 days  after  castration  and killed 0,4,8,  12, 
16, 20, 24, 30, 48, and 72 h  later. In A and B, total RNA  (20 pg) was analyzed by Northern  blot hybridization as described in the legend to 
Fig. 4. 
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FIG. 6. The effect of cycloheximide treatment to castrated 
rats with or without androgen stimulation. Four days after 
castration,  rats were either  untreated (lanes I and 2 )  or given testos- 
terone  propionate (lanes 3 and 4 )  for 30 h. Two h prior  to killing, 
cycloheximide (20 mg intraperitoneally) was administered (lanes 2 
and 4 ) .  Total  RNA (20 pg) was analyzed by Northern  blot analysis. 
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FIG. 7. Southern blot analysis of rat genomic DNA. Rat DNA 
(10 pg) was isolated  from dorsal  prostate ( A ) ,  ventral  prostate ( B ) ,  
and  Dunning  tumor H (C) and digested  with the following restriction 
enzymes  and electrophoresed on a 0.8% agarose gel: BamHI (lanes 
I), BglII (lanes 2 ) ,  PstI (lanes 3 ) ,  PuuII (lanes 4 ) ,  EcoRI (lanes 5), 
and SstI (lanes 6). DNA  was transferred to Biodyne  nylon membranes 
for hybridization  with  a  32P-labeled  DNA probe from the 5' portion 
of clone 11. 
terns when hybridized with radiolabeled DP1 cDNA (data  not 
shown). Furthermore,  the identical banding  patterns observed 
with  restriction enzyme  digests of prostate  and  tumor DNA 
suggested that a gross rearrangement of the  DP1 gene did not 
account for the lack of expression of DP1  in  the  Dunning 
R3327H tumor. 
Sequence Comparisons with DP1-The DP1 coding se- 
quence was compared  with three  types of transglutaminases 
(TG) (Fig. 8). Striking sequence similarity was observed  be- 
tween DP1 and guinea pig TG, rat keratinocyte TG, and 
human  clotting  factor  XIIIa  (human  placental f ctor XIII). A 
completely homologous active site required for TG activity 
was common to all four. These and additional properties, 
including similarity  in PI  (PI 6.0-6.12), molecular weight (71- 
77 kDa),  potential calcium  binding, and glycosylation sites, 
suggest that  DP1  is  rat  prostate  transglutaminase. 
DISCUSSION 
The full coding sequence  for dorsal  protein 1 (DPl), a  major 
androgen-regulated protein of rat  dorsal  prostate  and coagu- 
lating gland, was determined. The  transcription  initiation  site 
was identified by primer extension and  PCR methodology, 
and 3000 bp of cDNA were sequenced. The 2004-bp open 
reading frame encodes 668 amino acids and  predicts a molec- 
ular weight of 75,479 for DP1. The amino acid sequence 
aligned with the sequence of eight cyanogen bromide frag- 
ments of purified DP1,  authenticating  the sequence. The  DP1 
mRNA, approximately 3.2 kb by Northern blot analysis in 
rat coagulating  gland and  dorsal  prostate, was  similar in size 
to the cDNA sequenced. Androgen regulation of DP1 was 
demonstrated by a  decrease in  mRNA  subsequent  to androgen 
withdrawal by castration  and  an increase following androgen 
administration. Amino acid sequence comparisons revealed 
that  DP1  is a member of the  transglutaminase family and 
most likely accounts for the  TG activity previously described 
in  rat  prostate (40). 
Our  earlier studies indicated that  DP1  is a dimer of two 60- 
70-kDa subunits (9). The homology among  all cDNA clones 
selected with the DP1 polyclonal antibody suggested that 
DP1 is a homodimer. However, one of the nine cyanogen 
bromide cleavage fragments of DP1 protein did not  match  the 
amino acid  sequence  derived  from DP1 cDNA. The uniden- 
tified  9-amino  acid peptide may represent a contaminant of 
the  DP1  protein  preparation.  Its sequence likewise showed no 
homology with other members of the  TG family. Alterna- 
tively, DP1 may be heteromeric, with the DP1 antibody 
recognizing only one  subunit.  Examination of purified DP1 
on a low percentage gradient SDS-polyacrylamide gel reveals 
two closely migrating  bands spaced about 2 kDa apart with a 
smear  in between. Since  DP1  contains 12 potential glycosyl- 
ation sites (double underlined in Fig. 1) and may become 
glycosylated (11), this  disparity  in  banding  pattern may sim- 
ply reflect  differences in glycosylation. Rat coagulating gland 
cytosol and secretory  fluid are reported to  contain  at least two 
forms of TG (41). Thus,  although  the  authenticity of the  DP1 
cDNA is established, the origin of the unidentified cyanogen 
bromide cleavage peptide  remains unresolved. 
The  rate of decrease in  DP1 mRNA after androgen with- 
drawal by castration was somewhat slower than  that of the 
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. . . . . . . . . .  . . . . .  . . . . . . . . . . . . . . . . . . . . . . . .  zation of rat liver poly(A) RNA with a DP1-specific probe 
GP VGL-HKLV-VNFECDKLKAVKGYRNVIIGPA----U 691 failed to reveal hybridizing bands, suggesting that  DP1 may 
DP1 TCNPRKFI-VKFlSROVKEVHA-EKWLITK----U 6 6 8  indeed represent a new class of tissue TG. The tissue-specific 
F13a SOH-RKLI-ASUSSDSLRHVYG~ELDVOIORRPSUU 
RK OVHGVIOVDVA 9 R VGDSRSGENIPUAFRGCA-U 
. . . .  . .  . . . . . . . . . . . . .  
. . . .  . . . .  . . . . .  . . . . . . . .  712 distribution of DP1 mRNA among the lobes of the  rat prostate 
. . . . . . . . . . .  . . .  824 suggests that  DP1 is the prostate TG originally referred to as 
vesiculase (40). 
prostate TG)  and guinea pig liver transglutaminase ( G P )  (45, 
FIG. 8. Amino acid sequence comparisons between DP1 (rat The rat coagulating gland was, in fact, notable for its 
keratinocyte TG (RK) (49). Double  dots, identical amino acid lent cross-linking Of  seminal Vesicle proteins through the 
residues relative to DP1; single  dots, homologous amino acid residues formation of t-(y-g1utamyl)lysine bonds between polypeptide 
relative to  DP1. Gaps in the sequence (indicated by a blank for more chains (41,  54,  55). This  prostate enzyme, unique to coagulat- 
than 2 amino acids or a hyphen for a single amino acid) were inserted ing gland and dorsal prostate, has an important role in for- 
to achieve maximal sequence alignment. Amino acids at the active 
are underlined. One of the major rat seminal vesicle secretory proteins, SVIV, 
was shown to  act  as  an acyl donor and acceptor substrate for 
prostatein C3 subunit, the major androgen-regulated secretory TGs,  both from rat coagulating gland and guinea Pig liver* 
protein of rat ventral prostate (1-6). prostatein c 3  m~~~ The formation of SVIV products of several different molecular 
decreases to low levels 4-7 days after androgen withdrawal, weights  suggested that  TGs catalyzed both intra- and  inter- 
whereas substantial  amounts of DP1 mRNA  (4-5-fold higher) molecular cross-linking (57). Other modified forms of SVIV 
remain after  this withdrawal period (38, 42-44). Administra- were produced by TG in the presence of spermidine, an 
47), the a subunit of human factor XI11 (3'13a) (51), and rat secretion Of a Ca2+-dependent TG, which the cava- 
site with cysteine at its center are boxed. Potential Ca2+-binding sites mation Of the postejaculatory vagina1 Plug in rodents (56)' 
Androgen-regulated Transglutaminase from Rat Prostate 12667 
abundant  polyamine of seminal  plasma.  Rodents are  unique 
among  mammals  by  forming  a  copulatory  plug. Since the TG 
activity is required to stabilize the plug, it is conceivable that 
the prostate-specific TG evolved  in  rodents  for this purpose. 
Acknowledgment-We thank Claudia M. Noyes for peptide se- 
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